[1]樊肖冲),徐富兴),邢 飞),等.经皮穿刺微球囊压迫术治疗手术后复发性三叉神经痛及其负性情绪的疗效分析[J].郑州大学学报(医学版),2021,(01):77-80.
 FAN Xiaochong),XU Fuxing),XING Fei),et al.Analysis of percutaneous microballoon compression on clinical efficacy and negative emotion for patients with postoperative recurrent trigeminal neuralgia[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2021,(01):77-80.
点击复制

经皮穿刺微球囊压迫术治疗手术后复发性三叉神经痛及其负性情绪的疗效分析()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2021年01期
页码:
77-80
栏目:
应用研究
出版日期:
2021-01-20

文章信息/Info

Title:
Analysis of percutaneous microballoon compression on clinical efficacy and negative emotion for patients with postoperative recurrent trigeminal neuralgia
作者:
樊肖冲1)徐富兴1)邢 飞2)任 欢1)马乐天1)孔存龙1)温媛媛1)王 涛1)张 卫2)
1)郑州大学第一附属医院疼痛科 郑州 450052 2)郑州大学第一附属医院麻醉与围术期医学部 郑州 450052
Author(s):
FAN Xiaochong1) XU Fuxing1) XING Fei2) REN Huan1) MA Letian1) KONG Cunlong1) WEN Yuanyuan1) WANG Tao1) ZHANG Wei2)
1)Department of Painology,the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052 2)Department of Anesthesiology and Perioperative Medicine, the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052
关键词:
经皮穿刺微球囊压迫术 复发性三叉神经痛 负性情绪
Keywords:
percutaneous microballoon compression recurrent trigeminal neuralgia negative emotion
分类号:
R745.1+1
摘要:
目的:探讨经皮穿刺微球囊压迫术(PMC)治疗手术后复发性三叉神经痛的疗效及对负性情绪的影响。方法:选择2017年8月至2019年1月在郑州大学第一附属医院行PMC治疗手术后复发性三叉神经痛患者89例,于术前(T0)、术后1 d(T1)、1个月(T2)、3个月(T3)、6个月(T4)和12个月(T5)记录巴罗神经病学研究所疼痛量表(BNI-P)评分,评估手术疗效及并发症情况; 记录患者综合医院焦虑抑郁量表(HADS)评分及匹兹堡睡眠质量指数(PSQI)评分,评估患者的焦虑、抑郁和睡眠状态。结果:与T0时比较,患者在T1~T5时BNI-P评分、HADS评分及PSQI评分均明显降低(P<0.05),手术有效率分别为93.3%、95.5%、95.5%、94.4%和91.0%。本组患者有6例(6.7%)术后1 d疼痛未明显缓解,其中2例患者在术后2周时疼痛明显缓解; 随访期间有4例(4.5%)疼痛复发。结论:PMC具有疼痛缓解率高、复发率低等优点,且可明显改善TN所引起的负性情绪,可能是治疗术后复发性三叉神经痛的最佳选择,值得临床推广应用。
Abstract:
Aim:To investigate the efficacy of percutaneous microballoon compression(PMC)in the treatment of patients with postoperative recurrent trigeminal neuralgia(TN)and analyze the effects of PMC on the negative emotions of the patients.Methods:A total of 89 patients with postoperative recurrent TN were treated with PMC in our hospital from August 2017 to January 2019.The Barrow Neurological Institute pain intensity(BNI-P)score was recorded preoperatively(T0)and 1 day(T1), 1 month(T2), 3 months(T3), 6 months(T4), and 12 months(T5)postoperatively,which was used to measure clinical efficacy and its complications.The hospital anxiety and depression scale(HADS)and pittsburgh sleep quality index(PSQI)were recorded at the same time points and used to evaluate anxiety, depression and sleep status.Results:Compared with T0, the BNI-P, HADS and PSQI scores significantly decreased at T1-T5(P<0.05).The efficacies at the different time points were 93.3%, 95.5%, 95.5%, 94.4%, and 91.0%.In this study, 6 patients(6.7%)had no significant pain relief 1 day postoperatively, of whom 2 patients had significant pain relief 2 weeks postoperatively.In addition, 4 patients(4.5%)had recurrent pain during the follow-up period.Conclusion:PMC has unique advantages, such as high pain relief rate and low recurrence rate.Moreover, it significantly improves negative emotion caused by TN, so it appears to be regarded as an optimized choice for patients with recurrent TN after surgical procedures.

参考文献/References:

[1] 中华医学会神经外科学分会功能神经外科学组,中国医师协会神经外科医师分会功能神经外科专家委员会,上海交通大学颅神经疾病诊治中心.三叉神经痛诊疗中国专家共识[J].中华外科杂志,2015,53(9):657
[2] BERGENHEIM AT,ASPLUND P,LINDEROTH B.Percutaneous retrogasserian balloon compression for trigeminal neuralgia: review of critical technical details and outcomes[J].World Neurosurg,2013,79(2):359
[3] CHENG JS,LIM DA,CHANG EF,et al.A review of percutaneous treatments for trigeminal neuralgia[J].Neurosurgery,2014,10(Suppl 1):25
[4] DU Y,YANG D,DONG X,et al.Percutaneous balloon compression(PBC)of trigeminal ganglion for recurrent trigeminal neuralgia after microvascular decompression(MVD)[J].Ir J Med Sci,2015,184(4):745
[5] Headache classification committee of the international headache society(IHS)the international classification of headache disorders, 3rd edition[J].Cephalalgia,2018,38(1):1
[6] 郑磊磊,王也玲,李惠春.医院焦虑抑郁量表在综合性医院中的应用[J].上海精神医学,2003,15(5):264
ZHENG LL,WANG YL,LIU HC.Application of hospital anxiety and depression scale in general hospital: an analysis in reliability and validity[J].Shanghai Archives of Psychiatry, 2003, 15(5):264
[7] 刘贤臣,唐茂芹,胡蕾,等.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103
LIU XC,TANG MQ,HU L,et al.Reliability and validity of the Pittsburgh sleep quality index[J].Chin J Psychiatry,1996,29(2):103
[8] MONTANO N,PAPACCI F,CIONI B,et al.The role of percutaneous balloon compression in the treatment of trigeminal neuralgia recurring after other surgical procedures[J].Acta Neurol Belg,2014,114(1):59
[9] SPATZ AL,ZAKRZEWSKA JM,KAY EJ.Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions[J].Pain,2007,131(3):302
[10]ROGERS CL,SHETTER AG,FIEDLER JA,et al.Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of the Barrow Neurological Institute[J].Int J Radiat Oncol Biol Phys,2000,47(4):1013
[11]WANG JY,BENDER MT,BETTEGOWDA C.Percutaneous procedures for the treatment of trigeminal neuralgia[J].Neurosurg Clin N Am,2016,27(3):277
[12]CHEN JF,TU PH,LEE ST.Repeated percutaneous balloon compression for recurrent trigeminal neuralgia: a long-term study[J].World Neurosurg,2012,77(2):352
[13]URCULO E,ALFARO R,ARRAZOLA M,et al.Trochlear nerve palsy after repeated percutaneous balloon compression for recurrent trigeminal neuralgia: case report and pathogenic considerations[J].Neurosurgery,2004,54(2):505
[14]BROWN JA,CHITTUM CJ,SABOL D,et al.Percutaneous balloon compression of the trigeminal nerve for treatment of trigeminal neuralgia[J].Neurosurg Focus,1996,1(2):1
[15]BROWN JA,HOEFLINGER B,LONG PB,et al.Axon and ganglion cell injury in rabbits after percutaneous trigeminal balloon compression[J].Neurosurgery,1996,38(5):993
[16]LI FY,HAN S,MA Y,et al.Optimal duration of percutaneous microballoon compression for treatment of trigeminal nerve injury[J].Neural Regen Res,2014,9(2):179

备注/Memo

备注/Memo:
【基金项目】国家自然科学基金项目(81571082); 河南省科技攻关计划(国际科技合作领域)项目(182102410014); 河南省医学科技攻关计划项目(201602040)
【作者简介】樊肖冲,通信作者,男,1981年10月生,博士,副主任医师,研究方向:神经病理性疼痛的基础与临床,E-mail:xiaochong2002@126.com; 张卫,通信作者,女,1957年10月生,博士,主任医师,研究方向:麻醉药物基因组学、疼痛分子机制, E-mail:zhangw571012@126.com
更新日期/Last Update: 2021-02-15